Advertisement

PharmacoEconomics & Outcomes News

, Volume 842, Issue 1, pp 27–27 | Cite as

Sacral neuromodulation not good value in overactive bladder

Clinical study
  • 3 Downloads

Reference

  1. Harvie HS, et al. Cost Effectiveness of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial. Journal of Urology : 101097JU0000000000000656, 18 Nov 2019. Available from: URL: http://doi.org/10.1097/JU.0000000000000656

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations